CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event New debt or obligation
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CEO & President sold 2,662 shares at $20.72 ($55,157)
- 4 Planned sale Chief Medical Officer sold 880 shares at $20.72 ($18,234)
- 4 Planned sale Chief Commercial Officer sold 144 shares at $20.72 ($2,984)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale CEO & President sold 2,640 shares at $13.41 ($35,402)
- 4 Planned sale Chief Commercial Officer sold 1,038 shares at an average $13.29 ($13,794)
- 4 Planned sale Chief Medical Officer sold 4,425 shares at an average $13.30 ($58,842)
Page 10 of 40 · 796 filings